Array comparative genomic hybridization identifies high level of PI3K/Akt/mTOR pathway alterations in anal cancer

Wulfran Cacheux1,2, Petros Tsantoulis3, Adrien Briaux2

  • 1Département d'oncologie médicale, Institut Curie, Ensemble hospitalier, Hôpital René Huguenin, Saint-Cloud, France.

Cancer Medicine
|May 28, 2018
PubMed

Insights

Genomic alterations in anal squamous cell carcinoma (ASCC) are poorly understood. This study identified key genomic regions and pathways, particularly the PI3K/Akt/mTOR pathway, which is crucial for understanding ASCC recurrence and survival.

Area of Science:

  • Oncology
  • Genomics
  • Cancer Research

Background:

  • Anal squamous cell carcinoma (ASCC) is a rare malignancy with poorly understood genomic underpinnings.
  • Limited research exists on the specific genetic alterations driving ASCC development and progression.

Purpose of the Study:

  • To comprehensively characterize the genomic landscape of ASCC.
  • To identify frequently altered genes and pathways involved in ASCC.
  • To investigate the correlation between genomic alterations and clinical outcomes, including recurrence and overall survival.

Main Methods:

  • Array comparative genomic hybridization (aCGH) and targeted gene sequencing were employed.
  • Analysis was performed on 49 cases of ASCC.
  • Genomic data were integrated to identify significantly altered regions and pathways.

Main Results:

  • Frequent deletions were observed in regions including 11q22.3 (ATM), and gains in 3q26.32 (PIK3CA).
  • Recurrent homozygous deletions (e.g., TGFR2) and focal amplifications (e.g., DDR2, CCND1) were identified.
  • The PI3K/Akt/mTOR signaling pathway was significantly enriched, especially in recurrent tumors (64% vs. 30%).
  • A higher number of genomic alterations correlated with poor overall survival in recurrent ASCC patients.

Conclusions:

  • Somatic genomic alterations in ASCC involve specific deleted and gained regions, with ATM and PIK3CA being frequently affected.
  • The PI3K/Akt/mTOR pathway plays a critical role in ASCC pathogenesis and recurrence.
  • Genomic profiling can provide insights into ASCC prognosis and identify potential therapeutic targets.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.6K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.8K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.2K
Psychosexual Stages of Personality: Anal01:26

Psychosexual Stages of Personality: Anal

Sigmund Freud's theory of psychosexual development describes the anal stage as occurring between 18 months and three years of age. During this period, children derive pleasure from controlling and releasing their bowel movements. However, they quickly learn that societal expectations impose restrictions on when and where this can happen. This stage marks a critical point where children begin to develop a sense of control and mastery over their bodily functions, as well as their broader...
4.2K